Constant Therapeutics

Constant Therapeutics, LLC. is a clinical-stage company dedicated to developing Mas receptor agonists for the treatment of COVID-19, CNS, and rare diseases. Its lead candidate TXA127 is a pharmaceutical formulation of the natural human peptide angiotensin.